Teva Plan B OTC Application Fails Political Test After Clearing FDA Hurdle
This article was originally published in The Tan Sheet
Executive Summary
HHS Secretary Sebelius says Teva must show more evidence of how young adolescent females would use Plan B One-Step as an OTC. But obtaining such clinical data for the emergency contraceptive – in excess of what FDA already needed to approve it – appears nearly impossible, experts say.